Understanding Your Lump: Next Steps for the Upper Outer Quadrant
At a Glance
A lump in the upper outer breast, even near the armpit, does not by itself mean breast cancer has spread to lymph nodes. A timely exam, targeted imaging, and sometimes a core needle biopsy are needed to determine the cause.
Finding a new lump in the upper outer area of your breast, near your armpit, can be a frightening experience. It is natural to feel a surge of panic and wonder if its proximity to your armpit means a cancer has already spread to your lymph nodes. However, while this is the most common location for breast lumps to be found, the location itself does not determine your diagnosis or your prognosis [1][2].
(Note: This page describes the evaluation of a newly found lump. If you already have a biopsy-confirmed diagnosis, you may be further along in the pathway and should follow your care team’s individualized staging plan.)
Understanding the Anatomy
The upper outer quadrant (UOQ) is the section of the breast closest to the armpit. This area generally contains a higher volume of glandular tissue (the parts of the breast that make and carry milk) than other quadrants [3].
In some people, a small “tail” of breast tissue called the axillary tail of Spence extends even further into the armpit area. Because this quadrant is the most frequent site for breast cancer, doctors are very familiar with evaluating lumps here [1]. While some experts believe this is simply due to having more tissue in this area, no single explanation has been definitively proven [1][4].
Location vs. Spread
The most common fear when finding a UOQ lump is that because it is “near the lymph nodes,” it must have already spread. It is important to understand that:
- Location does not equal spread. Being physically close to the axillary (armpit) lymph nodes does not mean a cancer has moved into them. Many tumors in the UOQ are node-negative, meaning they have not spread to the lymph nodes [5].
- Biological factors matter more. Factors like a tumor’s size, its grade, and its hormone receptor status are much more important for prognosis than where in the breast a lump started [6][7].
- Imaging provides clues, not a diagnosis. Doctors use ultrasound to look at the axillary lymph nodes. They look for signs like cortical thickening or the loss of a normal fatty center (the hilum) to decide if a node looks suspicious enough to need its own needle biopsy [8][9]. An abnormal ultrasound is suggestive, but not definitive; testing the tissue is required.
Your Immediate Next Steps
Even if a lump is painless or you recently had a normal screening mammogram, a new lump requires timely clinical evaluation. The diagnostic process follows a standard path:
- Clinical Breast Exam: Your doctor will feel the lump to determine its size, texture, and whether it moves or feels “fixed” to the skin or chest wall [10].
- Diagnostic Imaging: Unlike a routine screening, diagnostic imaging focuses specifically on the area of concern.
- Under age 30: Ultrasound is usually the first step because it is highly effective at looking through dense young breast tissue [11][12].
- Age 30–39: Doctors may use ultrasound, a mammogram, or both [11].
- Age 40 and older: A diagnostic mammogram (often using 3D technology) is usually paired with a targeted ultrasound [11][13].
- Biopsy (If Needed): If imaging shows a suspicious mass (often labeled as BI-RADS 4 or 5), a biopsy is the only way to confirm what the lump is [14].
- A core needle biopsy is the standard method, where a hollow needle removes small cylinders of tissue for a pathologist to study under a microscope [14][15].
- During the biopsy, a tiny metal marker or clip is often placed at the site. This ensures that if the lump needs to be treated or removed later, the exact spot can be found again easily [16].
Waiting for Results
The period between a biopsy and receiving your pathology report is often the most difficult part of the process. Remember that a “suspicious” finding on an image is not a diagnosis. Your medical team’s goal is to ensure radiologic-pathologic concordance—meaning the tissue results match what was seen on the scans [17]. If a biopsy comes back benign but the imaging looked highly suspicious, further evaluation or a surgical biopsy may still be needed to be absolutely certain.
Common questions in this guide
Does a lump in the upper outer breast mean the cancer has spread to my armpit lymph nodes?
What should I do if I find a new lump in the upper outer breast?
Can a normal mammogram rule out a breast lump?
When does a breast lump need a biopsy?
What does an abnormal lymph node ultrasound mean?
Why is a clip placed after a breast biopsy?
What if my biopsy is benign but the imaging looked very suspicious?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does this lump feel like it is in the breast tissue itself or in the axillary tail of Spence?
- 2.If the mammogram is negative but I can still feel the lump, what is the next step to be certain?
- 3.How do my lymph nodes look on the ultrasound, and do any of them need a needle biopsy?
- 4.If a biopsy is needed, will you use a clip or marker so we can find this spot again later?
- 5.Based on the imaging, how likely is it that this is a benign condition, and what is our plan if the biopsy results don't match the imaging?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Non-randomness of the anatomical distribution of tumors.
Yu C, Mitchell JK
Cancer convergence 2017; (1(1)):4 doi:10.1186/s41236-017-0006-7.
PMID: 29623957 - 2
Tumor Site and Breast Cancer Prognosis.
Siotos C, McColl M, Psoter K, et al.
Clinical breast cancer 2018; (18(5)):e1045-e1052 doi:10.1016/j.clbc.2018.05.007.
PMID: 29941391 - 3
Adult cystic lymphangioma in the inner quadrant of the breast-Rare location for a rare disease: A case report.
Rusdianto E, Murray M, Davis J, Caveny A
International journal of surgery case reports 2016; (20()):123-6.
PMID: 26852362 - 4
Association between body mass index and localization of breast cancer: results from a nationwide inpatient database in Japan.
Konishi T, Fujiogi M, Michihata N, et al.
Breast cancer research and treatment 2021; (185(1)):175-182 doi:10.1007/s10549-020-05934-6.
PMID: 32949351 - 5
Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound.
Fu F, Zhang Y, Sun J, et al.
Acta radiologica (Stockholm, Sweden : 1987) 2022; (63(11)):1463-1468 doi:10.1177/02841851211054191.
PMID: 34719964 - 6
Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer
Sandoughdaran S, Malekzadeh M, Mohammad Esmaeil ME
Asian Pacific journal of cancer prevention : APJCP 2018; (19(6)):1617-1620 doi:10.22034/APJCP.2018.19.6.1617.
PMID: 29936787 - 7
Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.
He ZY, Wu SG, Yang Q, et al.
Medicine 2015; (94(48)):e2213 doi:10.1097/MD.0000000000002213.
PMID: 26632910 - 8
Do All Women With Abnormal Sonographic Axillary Lymph Nodes Need a Biopsy?
Amitai Y, Menes T, Aviram G, Golan O
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2016; (67(2)):173-8.
PMID: 26847811 - 9
The validity and clinical utility of axillary ultrasonography-guided fine needle aspiration biopsy in detection of nodal metastasis in early-stage breast cancer patients: a retrospective single-center experience.
Taşçı F, Metin Y, Metin NO, et al.
Turkish journal of medical sciences 2022; (52(4)):1160-1168 doi:10.55730/1300-0144.5419.
PMID: 36326392 - 10
ACR Appropriateness Criteria® Palpable Breast Masses.
, Moy L, Heller SL, et al.
Journal of the American College of Radiology : JACR 2017; (14(5S)):S203-S224 doi:10.1016/j.jacr.2017.02.033.
PMID: 28473077 - 11
ACR Appropriateness Criteria Palpable Breast Masses.
Harvey JA, Mahoney MC, Newell MS, et al.
Journal of the American College of Radiology : JACR 2016; (13(11S)):e31-e42 doi:10.1016/j.jacr.2016.09.022.
PMID: 27814822 - 12
Evaluation of Palpable Breast Abnormalities.
Dodelzon K, Katzen JT
Journal of breast imaging 2019; (1(3)):253-263 doi:10.1093/jbi/wbz040.
PMID: 38424759 - 13
[Diagnostic value of digital breast tomosynthesis for mass lesions in dense breast].
Lü XJ, Liu N, Li Q, et al.
Zhonghua yi xue za zhi 2019; (99(39)):3110-3113 doi:10.3760/cma.j.issn.0376-2491.2019.39.014.
PMID: 31648457 - 14
Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short text.
Lavoué V, Fritel X, Antoine M, et al.
European journal of obstetrics, gynecology, and reproductive biology 2016; (200()):16-23.
PMID: 26967341 - 15
Percutaneous Ultrasound-Guided Core Needle Biopsy: Comparison of 16-Gauge versus 14-Gauge Needle and the Effect of Coaxial Guidance in 1065 Breast Biopsies - A Prospective Randomized Clinical Noninferiority Trial.
Gruber I, Oberlechner E, Heck K, et al.
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2020; (41(5)):534-543 doi:10.1055/a-1014-2628.
PMID: 31791085 - 16
Long-term safety and efficacy of breast biopsy markers in clinical practice.
Smith S, Taylor CR, Kanevsky E, et al.
Expert review of medical devices 2021; (18(1)):121-128 doi:10.1080/17434440.2020.1852928.
PMID: 33233969 - 17
Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.
Park VY, Kim EK, Moon HJ, et al.
Ultrasonography (Seoul, Korea) 2018; (37(2)):107-120 doi:10.14366/usg.17049.
PMID: 29169231
This page is for informational purposes only and does not constitute medical advice. A healthcare professional should promptly evaluate a new breast or armpit lump and interpret your imaging or biopsy results.
Get notified when new evidence is published on female breast upper-outer quadrant cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.